Clinical Trial Update: A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial evaluating a risk-oriented therapeutic strategy in adults with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Northern Italy Leukemia Group | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED